chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.3
Sex: M
Vaccine: DTAP, HBHEPB, MMR, VARCEL
Symptoms: Body temperature, Pruritus, Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 5 year old male who on 14-FEB-2002 was vaccinated with a dose of Varivax (Lot# 635450/1142K). Concomitant vaccine administered on the same day include a dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid, a dose of Comvax, and a dose of MMR II. On 18-APR-2006 the patient broke out with 50-75 varicella lesions in different stages. It was reported that some lesions were on his face and the majority of the lesions were around his rectum. The patient did not have a temperature. The patient was given Benadryl for itching. It was reported that the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: DTP, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 4 year old female who on 17 Oct 2002 was vaccinated with a dose Varivax. Concomitant therapy included DPT. On 26 Apr 2006 the patient developed less than 50 varicella lesions on her face and legs. The patient did not have a fever. Unspecified medical attention was sought. At the time of the report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 31.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a 31 year old female in her second trimester of pregnancy with no medical history or allergies who in April 1995, was vaccinated SC with a dose of Varivax. There was no concomitant therapy. The patient reported that on 27 APR 2006, blood work revealed that she was "not immune to chickenpox anymore." Unspecified medical attention was sought. At the time of this report, the patient had not recovered. No further information is available.
Age: 1.3
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature, Varicella
Clinical narrative: Information has been received from a nurse practitioner concerning her 7 year old white son who on 14-FEB-2000 was vaccinated with a first dose of Varivax. It was noted that the patient was vaccinated at a prior pediatrician's office. On 28-APR-2006, the patient experienced breakthrough varicella with six lesions and no fever thus far. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been received from the reporter who indicated that in April 2006, the patient was diagnosed with varicella. No further information is expected. The nurse also reported that her three other children experienced a similar event after therapy with Varivax (WAES number 0605USA00191, 0605USA00089, and 0605USA00082).
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Culture throat positive, Pharyngolaryngeal pain, Varicella
Clinical narrative: Information has been received from a health professional concerning a 7 year old white male with no medical history or allergies who on 23 Mar 2000 was vaccinated subcutaneously in the right arm with Varivax (lot # 632275/1453J). There were no reported prior adverse events to vaccination for the patient or siblings. On 17 Apr 2006, the patient was seen by a physician for a sore throat and was treated for strep. It was noted that he had a throat culture done and it was positive (previously reported as negative). He was treated with amoxicillin. On 27 Apr 2006 the patient was seen by a physician and it was documented that he dad the chicken pox. It was noted that greater than 100 lesions comparable to varicella were observed. Benadryl was prescribed. Medical attention was sought. The outcome was reported as recovered (date not specified). No product quality complaint was involved. The patient's sister (WAES0605USA04173) was also diagnosed with breakthrough chicken pox. No additional information is expected.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature increased, Pyrexia, Varicella
Clinical narrative: Information has been received from a nurse practitioner concerning her 13 year old white son with no known medical history or allergies who on 21-FEB-1996 was vaccinated with a dose of Varivax. The lot number was unknown but it was reported that the patient received the same lot as his female sibling (WAES # 0605USA00191). On 11-APR-2006, the patient experienced full blown breakthrough varicella with 100 lesions and a fever of 100 to 101 degrees Fahrenheit. Unspecified medical attention was sought and he was treated with acyclovir. Subsequently, the patient recovered on an unspecified date. A product quality complaint was not involved. Additional information has been requested. The nurse also reported that her three other children had similar events after therapy with Varivax (WAES number 0605USA00089, 0605USA00191, and 0605USA00017).
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature increased, Pyrexia, Varicella
Clinical narrative: Information has been received from a nurse practitioner concerning her 6 year old white son who was vaccinated on 20-MAR-2001 with a first dose of Varivax. On 27-APR-2006, the patient experienced full blown breakthrough varicella with 100 lesions and a fever of 100 to 101 degrees Fahrenheit. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has been received from the reporter who indicated that on 27-APR-2006 the patient was diagnosed with varicella. Additional information is not expected. The nurse also reported that her three other children had a similar event after therapy with Varivax (WAES number 0605USA00191, 0605USA00082, and 0605USA00017).
Age: 1.0
Sex: M
Vaccine: PNC, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning a 15-month-old white male with gastrooesophageal reflux, failure to thrive and coarctation of the bicuspid valve who on 09-JAN-2006 was vaccinated SC with the first dose of Varivax (Lot # 649281/0656P). Concomitant vaccinations administered on that same day included the fourth IM dose of Prevnar (Lot # B0863D). The RN reported that on 16-APR-2006, the patient developed a varicella rash/outbreak. Medical attention was not sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature increased, Pyrexia, Varicella
Clinical narrative: Information has been received from a nurse practitioner concerning her 11 year old white daughter, with no medical history and no allergies, who on 26-FEB-1996 was vaccinated with a first dose of Varivax (Lot# 608578/0389B). On 01-APR-2006 the patient experienced full blown breakthrough varicella with 100 lesions and a fever of 100 to 101 degrees Fahrenheit. Unspecified medical attention was sought and she was treated with acyclovir. Subsequently, the patient recovered on an unspecified date. A product quality complaint was not involved. Additional information has been requested. The nurse reported that her three other children had similar events after therapy with Varivax (WAES number 0605USA00089, 0605USA00082, and 0605USA00017).
Age: 1.0
Sex: F
Vaccine: FLUX, HIBV, MMR, VARCEL
Symptoms: Exposure to communicable disease, Pyrexia, Rash, Skin lesion, Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an 18-month-old female with no pertinent medical history or allergies, who on 14-OCT-2005 was vaccinated subcutaneously with a dose of Varivax (lot# 648083/0072P). Concomitant vaccinations included MMR (manufacturer unknown), Hib conj vaccine (OMPC) (manufacturer unknown), influenza virus vaccine (unspecified) and concomitant therapy included sodium fluoride. On 27-APR-2006 the patient developed chickenpox with 40-50 lesions. She had a fever but it resolved. Unspecified medical attention was sought. No laboratory or diagnostic tests were performed. It was noted that two weeks prior to the rash, she was exposed to chickenpox and shingles. At the time of the report the patient had not recovered from the chickenpox. No product quality complaint was involved. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Exposure to communicable disease, Pharyngitis streptococcal, Skin lesion, Streptococcal identification test negative, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old white female with a history of otitis who on 10-MAR-1998 was vaccinated SC in the left with a first dose of Varivax. Illness at the time of vaccination included otitis. On 17-APR-2006 the patient was seen in the office for possible strep throat. Cultures were done, which were negative for strep, and the patient was treated with amoxicillin. On 25-APR-2006 the patient presented to the office. Over the previous 16 hours she had broken out in lesions on her trunk, arms, face and ears. There were about 40 lesions. She was afebrile. She was treated with Benadryl. The health department took pictures and a swab and determined that the patient had varicella. It was reported that the patient's father was immunized with smallpox vaccine two weeks prior, he was doing a plasma study for servicemen. There was no product quality complaint involved. Follow-up information was received by the registered nurse which indicated that on 24-APR-2006 in the PM lesions began on the patient's face and hand (about 20). It was reported that the patient had exposure to varicella. On 24-APR-2006 a skin swab was taken from a vesicle and a varicella zoster DFA was performed that was questionable. A virus culture was also performed, no varicella zoster was isolated. It was reported that the patient's brother (WAES# 0605USA00024) experienced a similar reaction after vaccination with Varivax. Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: VARCEL
Symptoms: Virus culture negative
Clinical narrative: Information has been received from a registered nurse concerning a 9 year old white female with a history of otitis who on 10-MAR-1998 was vaccinated SC in the left with a first dose of Varivax. Illness at the time of vaccination included otitis. On 17-APR-2006 the patient was seen in the office for possible strep throat. Cultures were done, which were negative for strep, and the patient was treated with amoxicillin. On 25-APR-2006 the patient presented to the office. Over the previous 16 hours she had broken out in lesions on her trunk, arms, face and ears. There were about 40 lesions. She was afebrile. She was treated with Benadryl. The health department took pictures and a swab and determined that the patient had varicella. It was reported that the patient's father was immunized with smallpox vaccine two weeks prior, he was doing a plasma study for servicemen. There was no product quality complaint involved. Follow-up information was received by the registered nurse which indicated that on 24-APR-2006 in the PM lesions began on the patient's face and hand (about 20). It was reported that the patient had exposure to varicella. On 24-APR-2006 a skin swab was taken from a vesicle and a varicella zoster DFA was performed that was questionable. A virus culture was also performed, no varicella zoster was isolated. It was reported that the patient's brother (WAES# 0605USA00024) experienced a similar reaction after vaccination with Varivax. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a nurse concerning her 4.5 year old grandson with celiac disease who was vaccinated with Varivax. In April 2006, the patient experienced a mild to moderate breakthrough chicken pox. Unspecified medical attention was sought. At the time of this report the patient had not recovered. No product quality complaint was involved. Follow up information indicated that no additional information was available. No additional information is expected.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister, Erythema, Pyrexia, Varicella
Clinical narrative: Information has been received from a consumer concerning her 24 month old white son with no history or allergies who on 05-NOV-2004 was vaccinated in the left arm with a first dose of Varivax (lot # 648309/0277P). There was no concomitant medication and no illness at the time of vaccination. ON 15-NOV-2004, 10 to 14 days later, the patient experienced a fever of 101F and 13 chickenpox lesions on face, scalp and trunk. Treatment included Neosporin to the facial lesion. No labs or diagnostic studies were performed. The patient recovered on 19-NOV-2004. Medical attention was sought. No product quality complaint was involved. Follow up information was received from the physician who reported that on 18-NOV-2004 the patient developed multiple vesicles with surrounding erythema on the trunk and extremities. The patient also had a fever, by history. He reported that the patient recovered on 21-NOV-2004. Additional information is not expected.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a woman in a physician's office concerning an 8 year old black female who on 04-AUG-1999 was vaccinated in the left arm with a first dose of Varivax (lot 628697/1838H). On 12-APR-2006 the patient experienced "<50". It was unknown if medical attention was sought. No additional information has been provided. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Vaccination complication
Clinical narrative: Information has been received from a woman working in a physician's office concerning a 10 year old female who was vaccinated with a dose of Varivax. Subsequently, the patient experienced an adverse event. It was reported that the patient had recovered. Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a woman at a physician's office concerning a 7 year old female who was vaccinated with a dose of Varivax. Subsequently, the patient developed chickenpox. It was reported that she recovered on an unspecified date. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 4-5 year old patient who was vaccinated with a dose of Varivax. "Within the past 2 weeks", in April or May 2006, the patient experienced mild breakthrough. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a male patient who on 19-APR-2001 was vaccinated with a dose of Varivax (lot # 635453/0756K). On an unspecified date, the patient developed a mild case of breakthrough chickenpox. Unspecified medical attention was sought. The patient subsequently recovered. A product quality complaint was not involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) and a mother of a student concerning another child in elementary school who was vaccinated with a dose of Varivax. It was reported that the patient now has breakthrough chickenpox after an outbreak occurred in the elementary school. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a health professional indicated that the index case was an immunized individual. This is a consolidation of two reports concerning the same patient. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a health professional concerning a 5 year old Hispanic male, with no known allergies, who on 06-JUN-2001 was vaccinated with a first dose in the right deltoid of Varivax (Lot# 635453/0756K). There was no illness at the time of vaccination. Subsequently, the patient experienced mild case of breakthrough chickenpox. It was reported that the patient had recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a health professional indicated that on 03-MAY-2006 the patient experienced lesions on his body that were diagnosed as varicella. It was reported that the patient recovered on 12-MAY-2006. Additional information is not expected. Two of the patient's brothers experienced chickenpox following vaccination with Varivax (WAES# 0605USA00678 and 0605USA00813).
Age: 1.0
Sex: M
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 5 year old Hispanic male, with no known allergies, who on 06-JUN-2001 was vaccinated with a first dose in the right deltoid of Varivax (Lot# 635453/0756K). There was no illness at the time of vaccination. Subsequently, the patient experienced mild case of breakthrough chickenpox. It was reported that the patient had recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a health professional indicated that on 03-MAY-2006 the patient experienced lesions on his body that were diagnosed as varicella. It was reported that the patient recovered on 12-MAY-2006. Additional information is not expected. Two of the patient's brothers experienced chickenpox following vaccination with Varivax (WAES# 0605USA00678 and 0605USA00813).
Age: 1.0
Sex: M
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician, via a company representative, concerning a 4 year old male, with no known drug reactions or allergies, who on 06-JUN-2001 was vaccinated (route unknown) with a 0.5 mL dose of Varivax (Lot # 635453/0756K). On 20-APR-2006 the patient developed chickenpox. Unspecified medical attention was sought. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician, via a company representative, concerning a 4 year old male, with no known drug reactions or allergies, who on 06-JUN-2001 was vaccinated (route unknown) with a 0.5 mL dose of Varivax (Lot # 635453/0756K). On 20-APR-2006 the patient developed chickenpox. Unspecified medical attention was sought. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician, via a company representative, concerning a 4 year old male, with no known drug reactions allergies, who on 06 Jun 2001 was vaccinated (route unknown) with a 0.5 mL dose of Varivax (Lot# 635453/0756K). On 03 May 2006 the patient developed chickenpox. Unspecified medical attention was sought. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL, VARCEL, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician, via a company representative, concerning a 4 year old male, with no known drug reactions allergies, who on 06 Jun 2001 was vaccinated (route unknown) with a 0.5 mL dose of Varivax (Lot# 635453/0756K). On 03 May 2006 the patient developed chickenpox. Unspecified medical attention was sought. At the time of this report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Age: 1.5
Sex: F
Vaccine: DTP, VARCEL
Symptoms: Rash, Varicella
Clinical narrative: Initial and follow-up information has been received from a registered nurse concerning a 29-month-old female (previously reported as male) with no pertinent medical history and no drug reactions/allergies who on 13-APR-2005 was vaccinated in the right thigh with a first dose of Varivax (Lot # 648305/0826P). Concomitant vaccination included a fourth dose of diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid given in the left thigh. Other concomitant therapy included FLOVENT and ZYTREC. On 15-MAR-2006 the patient developed breakthrough chickenpox. Follow-up information from the nurse further specified that the patient developed the rash on the back of his neck, scalp, face and groin. The patient was treated with acyclovir. The patient was reported as recovered on 29-MAR-2006. The nurse also noted that the patient was recovering from otitis media at the time of vaccination. There was no product quality complaint. No further information was available. Additional information is not expected.
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a licensed practical nurse concerning a college-aged male who in approximately 2003 was vaccinated with a dose of Varivax. In approximately May 2006 the patient had a varicella titer drawn that did not show seroconversion. The varicella IgG titer came back as equivocal. No other symptoms were noted. Unspecified medical attention was sought. No other information was available. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 6 year old Hispanic female with no pre-existing allergies, birth defects, or medical conditions who on 20 Jan 1998 was vaccinated with a dose of Varivax (lot# 624722/1325E). There was no illness at the time of vaccination. Subsequently the patient developed a mild case of breakthrough chickenpox. Unspecified medical attention was sought. Subsequently, the patient recovered. No further information was available. There was no product quality complaint. Follow up information received from a medical assistant indicated that on 06 Jun 2001 the patient was vaccinated in the right deltoid with a second dose of Varivax. ( Lot # 635453/0756K). On 05 May 2006, the patient was diagnosed varicella, noted to be lesions to the body. The outcome was recovered on 15 May 2006. No additional information is expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Fatigue, Pyrexia, Skin lesion, Varicella, Varicella post vaccine
Clinical narrative: Initial and follow-up information has been received from a registered nurse concerning an 8 year old white female with no pertinent medical history and no allergies who on 27-JUL-1998 was vaccinated in the left thigh with a first dose of Varivax (lot # 626688/0650H). Concomitant therapy included BENADRYL and ALAVERT. On 25-FEB-2006 (previously reported as 22-FEB-2006), the patient developed breakthrough chickenpox. In follow-up, the nurse also noted that the patient had contact with a person who had chickenpox. On 25-FEB-2006, the child presented with fatigue, fever and lesions on face and trunk. The patient was treated with oral acyclovir and recovered on an unknown date. There was no illness at the time of vaccination. No product quality complaint was involved. Additional information is not expected.
Age: 17.0
Sex: M
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a licensed practical nurse concerning a 17 year old white male who on 18 Apr 2006 was vaccinated SC with a 0.5 mL first dose of with Varivax (lot# 650389/0951R) as part of his school requirements. Concomitant vaccination on the same day included a dose of Boostrix and a dose of Menactra. On 03 May 2006, in the a.m., the patient was seen by a physician for lesions on his arms, trunks, and in his hair line. The patient recovered on an unspecified date. A product quality complaint was not involved. No further information is expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 7-year-old male with no pertinent medical history or allergies, who on 24-APR-2000 was vaccinated in the right thigh with a dose of Varivax (lot #632724/0087K). There was no concomitant medication. On 27-APR-2006 the patient experienced breakthrough chickenpox. Unspecified medical attention was sought and the patient was treated with topical acyclovir. No laboratory or diagnostic tests were performed. It was reported that the patient recovered on an unspecified date. The reporter considered the patient's adverse experience to be an other important medical event. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a licensed practical nurse concerning her college aged son who 2-4 years ago was vaccinated with a dose of Varivax. A recent varicella titer was equivical with an IgG of 0.98, did not show seroconversion. Unspecified medical attention was sought. It was noted that no other symptoms were noted. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 5 year old Hispanic male, with no known allergies, who on 06 Jun 2001 was vaccinated with a first dose in the right deltoid of Varivax (Lot # 635453/0756K). Subsequently the patient experienced a mild case of breakthrough chickenpox. It was reported that the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a health professional indicated that on 20 Apr 2006 the patient had general lesions on his body since the morning. The patient was diagnosed with chickenpox. It was reported that the patient recovered on 27 Apr 2006. The patient's chickenpox was considered to be an other important medical event by the reporter. Additional information is not expected. Two of the patient's brothers experienced varicella following vaccination with Variavax (WAES # 0605USA00668 and 0605USA00678).
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February 2006 the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February 2006, the patient breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child who was vaccinated with a dose of VARIVAX (Merck). The RN reported that in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February  2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Vaccination failure, Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported that in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Vaccination failure, Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child who was vaccinated with a dose of Varivax. The RN reported hat in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse (RN) concerning an elementary aged child was vaccinated with a dose of Varivax. The RN reported that in February 2006, the patient developed breakthrough chickenpox which was considered to be a light, mild case. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 9-year-old white female with no known allergies who on 16-OCT-2000 was vaccinated with a  dose of Varivax. On 27-APR-2006 the patient developed chickenpox. She was seen and diagnosed on 28-APR-2006. No additional information is expected.
Age: 1.1
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old female who on 01-MAY-1996 was vaccinated with a first dose of Varivax. Concomitant vaccination included a first dose of MMR II. On 12-APR-2006 the patient developed a "bad case" of breakthrough chickenpox disease. Unspecified medical attention was sought. Subsequently, the patient recovered. No further information was available. The patient's additional vaccination history includes: first, second, third and fourth doses of diphtheria toxoid (+) Hib conj vaccine (CRM197) (+) pertussis whole cell vaccine (+) tetanus toxoid (manufacturer unspecified) on 05-JUN-1995, 21-AUG-1995, 20-OCT-1995, and 30-JUL-1996 respectively. First, second, third and fourth doses of hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unspecified) on 08-APR-1995, 05-JUN-1995, 30-JUL-1996, and 29-AUG-2001 respectively. One dose of hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (manufacturer unspecified) on 05-JUN-1995. Doses of influenza virus split virion 3v vaccine inactivated on 04-DEC-2000 (FLUSHIELD) (lot # 4008210). On 09-NOV-2004 (FLUZONE) (lot # U1515AA), and 29-NOV-2005 (FLUZONE) (lot # U1916AA). One dose of poliovirus vaccine inactivated (unspecified) (IPOL) (lot # R1366) on 21-AUG-2000. A second dose of MMR II (lot # "0577") on 21-AUG-2000. First, second and third doses of poliovirus vaccine live oral (manufacturer unspecified) on 05-JUN-1995, 21-AUG-1995, and 30-JUL-1996 respectively. First and second doses of Infanrix on 21-AUG-2000 (lot # U0137BA) and 15-JUL-2005. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 20 month old male who on 20-JUL-2005 was vaccinated SC in the left thigh with a first 0.5 ml dose of Varivax (lot # 650224/1107F). Concomitant vaccination included a 0.5 ml first dose of MMR II (lot # 646857/0850F) and a 0.5 ml fourth dose of Prevnar (lot # A67185K). On 27-MAR-2006 the patient developed breakthrough chickenpox disease. Unspecified medical attention was sought. Subsequently, the patient recovered. No further information was available. The patient's additional vaccination history includes: First, second, third, and fourth doses of Infanrix on 14-SEP-2004 (lot # AC21A003BA), 24-NOV-2004 (lot # AC21A005AA), 12-JAN-2005 (lot # AC21A010CA), and 01-DEC-2005 (lot # AC14A007AA) respectively. Doses of Fluzone on 12-JAN-2005 (lot # U1557AA) and 01-DEC-2005 (lot # U1916AA). First, second, third, and fourth doses of Prevnar on 14-SEP-2004 (lot # 495-932), 24-NOV-2004 (lot # A57561A), 12-JAN-2005 (lot # A74399D), and 20-JUL-2005 (lot # A67185K) respectively. One dose of hepatitis B virus vaccine (manufacturer unspecified) on 08-JUL-2004. Additional information is not expected.
Age: 1.1
Sex: F
Vaccine: HBHEPB, IPV, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old female who on 18-DEC-2001 was vaccinated SC in the left thigh with a 0.5 ml first dose of Varivax (lot# 638653/1890K). Concomitant vaccination included a 0.5 ml third dose of Comvax (lot # 638434/1639K), and a 0.5 ml third dose of IPOL (lot # T1273-2). Concomitant therapy also included tuberculin purified protein derivative. On 29-JAN-2006 the patient developed break through chickenpox. No medical attention was sought. Subsequently, the patient recovered. No further information was available. The patient's additional vaccination history includes: First, second, third, fourth, and fifth doses of Infanrix (lot # 992A2), 24-SEP-2001 (Infanrix) (lot #998A), 12-JUN-2002 (Tripedia) (lot # UO543BA), and 03-AUG-2005 (manufacturer unspecified) respectively. One dose of hepatitis B virus (manufacturer unspecified) on 25-OCT-2000. One dose of Hib (lot # 639027/0267L). First, second and third doses of Comvax on 25-OCT-2000 (manufacturer unspecified), 08-JAN-2001 (lot # 637687/1408K), and 18-DEC-2001 (lot # 638434/1693K) respectively. Doses of Fluzone on 01-DEC-2003 (lot # U1098AA), 07-JAN-2004 (lot # U1098AA), and 19-DEC-2005 (lot # U1936AA). First, second, third, and fourth doses on 08-JAN-2001 IPOL (lot # T01202), 26-APR-2001 (IPOL) (lot # T04843), 18-DEC-2001 (IPOL) (lot # T12732) and 03-AUG-2005 (manufacturer unspecified) respectively. First and second doses of MMR II on 12-JUN-2005 (lot# 641462/0128M) and 13-AUG-2005 (manufacturer unspecified). One dose of pneumococcal conj vaccine (unspecified) (manufacturer unspecified) (lot # 472-045) on 08-JAN-2001. Additional information is not expected.
Age: 1.3
Sex: M
Vaccine: DTAP, IPV, MMR, PNC, VARCEL
Symptoms: Vaccination failure, Varicella
Clinical narrative: Information has been received from a health professional concerning a 5-year-old male who on 25-JUN-2001 (Lot # 635662/1249K) and 04-OCT-2001 (Lot # 636263/1336K) was vaccination SC in the left arm with a first and second dose 0.5 mL dose of Varivax. Concomitant therapy that day included: a first (Lot # 630634/0103K), second (Lot # 639572/0733L), and third (Lot # 646899/0951N) dose of 0.5 mL MMR II on 25-JUN-2001, 04-OCT-2001, and 20-AUG-2004: a third (DTAa978a2), a forth (Batch # DTPa997A2) and fifth (Batch # 630A2) 0.5mL dose of Infanrix on 09-JAN-2001, 04-OCT-2001, and 20-AUG-2004; a third (T1186-2) and forth (X0707) dose of IPOL on 04-OCT-2001 and 20-AUG-2004; and a first (472555), second (474946), third (474946), and forth (474946) 0.5mL dose of Prevnar on 08-FEB-2001, 10-APR-2001, 25-JUN-2001, and 04-OCT-2001. Other vaccinations included: a first (Lot # 467-008) and second (Lot # 473-441) 0.5 mL dose of Acel-Imune on 30-AUG-2000 and 02-NOV-2000: a first and second dose of hepatitis A virus vaccine inactivated (manufacturer unknown) on 09-APR-2004 and 10-OCT-2003; a first (MSD-Lot # 634237/0289K-0.5mL) and second (MSD-Lot # 636994/1033K-0.5mL) and third (manufacturer unknown) dose of Comvax on 30-AUG-2000, 02-NOV-2000, and 26-JUN-2001; a first, second (U1270AA), third (U1557AA), and forth (U1936AA) 0.5mL dose of Fluzone; and a first (T0025-2) and second (R1422-2) 0.5mL dose of IPV MERIEUX on 30-AUG-2000 and 02-NOV-2000. On 05-MAR-2006 the patient experienced chickenpox. Subsequently, the patient recovered from chickenpox. No additional information is expected.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 10-year-old female who on 25-MAR-1999 was vaccinated with a first dose of Varivax. Additional therapies included: a first dose of DTaP on 22-MAR-2000; a first, second, third, and fourth dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid on 22-MAR-2000; a first, second, third, and fourth dose of diphtheria toxoid (+) Hib conj vaccine (+) pertussis whole cell vaccine (+) tetanus toxoid on 06-SEP-1995, 22-NOV-1995, 18-JAN-1996, and 11-JUN-1997; a first, second, and third dose of hepatitis A (manufacturer unknown) on 29-JAN-1998, 09-MAR-1998, and 21-OCT-1998; a first, second, and third dose of Recombivax (manufacturer unknown) on 12-JUL-1995, 06-SEP-1995, and 20-AUG-1996; a 0.5mL dose of Fluvirin (Lot # 765754 on 05-NOV-2003; a 0.5mL dose of Fluzone (Lot # U1935AA on 17-DEC-2005; a first dose of poliovirus vaccine on 22-MAR-2000; a first and second dose of MMR II (manufacturer unknown) on 22-MAR-2000 and 20-AUG-1996; a first and second dose of poliovirus vaccine live oral on 06-SEP-1995 and 22-NOV-1995; a first and second dose of tuberculin purified protein derivative on 11-JUN-1997 and 21-OCT-1998; and a first dose of Trihibit on 24-SEP-2004. On 16-MAR-2006 the patient experienced breakthrough chickenpox disease. Subsequently, the patient recovered from the chickenpox. No additional information is expected.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 4-year-old female who on 08-FEB-2002 was vaccinated SC in the left arm with a first 0.5mL dos eof Varivax (Lot # 635794/0582L). Concomitant therapy that day included a first 0.5mL dose of MMR II (Lot # 639621/0899L). Other therapy included: a second 0.5mL dose of MMR II (Lot # 646585/0852P) administered on 03-FEB-2005; a first, second, third, fourth, and fifth 0.5mL dose of Infanrix on 02-APR-2001 (Lot # 983a2), 05-JUN-2001 (Lot # DTPa997a2), 02-AUG-2001 (Lot # DTPa505a2), 10-JUL-2002 (Lot # DTaP552A2), and 03-FEB-2005 (Lot # DTPa639A2); first 0.5mL dose of hepatitis A virus vaccine inactivated (Lot # 648218/0858P) on 28-FEB-2005; a first, second, and third 0.5mL dose of hepatitis B virus (+) Hib conj vaccine on 02-APR-2001 (Lot # 636992/1968K), 05-JUN-2001 (Lot # 638842/1763K), and 10-JUL-2002 (Lot # 643051/0284M); a 0.25mL dose of Fluzone on 05-DEC-2003 (Lot # U1269AA), 08-JAN-2004 (Lot # U1133AA), and 16-NOV-2004 (Lot # U1515AA); a first, second, third, and fourth 0.5mL dose of IPOL on 02-APR-2001 (Lot # R0516), 05-JUN-2001 (Lot # T0563), 10-JUL-2002 (Lot # UO422), and 03-FEB-2005 (Lot # W07501); and a first and second 0.5mL dose of Prevnar on 02-APR-2001 (Lot # 472046) and 02-AUG-2001 (Lot # 479-298). On 14-JAN-2006 the patient experienced breakthrough chickenpox disease. Subsequently, the patient recovered. No additional information is expected.
Age: 1.1
Sex: M
Vaccine: HBHEPB, MMR, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning an 8-year-old white male with asthma who on 29-MAR-1999 was vaccinated SC in the left arm with a first 0.5 mL dose of Varivax (Lot # 629642/0114J). Concomitant therapy included a third 0.5 mL dose of Comvax (Lot # 629304/1616H) administered IM on 29-MAR-1999 and a first and second 0.5 mL dose of MMR II administered on 29-MAR-1999 (Lot # 626986/1756H - administered SC) and 17-OCT-2002 (Lot # 643501/0634M). Other therapy included a first, second, third, forth and firth 0.5 mL dose of Infanrix on 15-APR-1998, 18-JUN-1998 (Lot # DTPA847A2) administered IM, 20-AUG-1998 (Lot # DPTA852A2) administered IM, 04-JU-1999 (Lot # 909A) administered IM, and 17-OCT-2002 (LOt # 568b9); a first dose of hepatitis B virus vaccine rHBsAg (yeast) (manufacturer unknown) on 17-FEB-1998; the second and third 0.5 mL dose of Hibtiter on 18-JUN-1998 (Lot # M240RK) and 20-AUG-1998 (Lot # M010RN) administered IM; a second does of HIB conj-hepatitis B vaccine (manufacturer unknown) on 15-APR-1998); a 0.5 mL dose of Fluvirin on 14-NOV-2003 (Lot # 767757) and 12-DEc-2003; a 0.5 mL dose of Fluzone (Lot # U1515AA); a 0.5 mL dose of Ipol (W0010); a first, second, and third dose of Orimune on 15-APR-1998, 18-JUN-1998 9Lot # 0774A), on d04-JUN-1999 (Lot #0801F); and a 0.1 mL dose of "PPD" (Lot # C2078AA) on 31-OCT-2005. On 17-MAR-2006 the patient experienced chickenpox. Subsequently, the patient recovered from chickenpox. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: DTAP, HIBV, IPV, VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 7-year-old female who on 24-MAR-1999 was vaccinated with the first dose of Varivax. Concomitant therapy included a first, second, third, fourth, and fifth dose of DTaP on 19-MAY-1998, 16-JUL-1998, 15-SEP-1998, 24-MAR-1999, and 28-MAR-2002, a first, second, third, and fourth dose of PedvaxHIB (manufacturer unknown) on 19-MAY-1998, 16-JUL-1998, 15-SEP-1998, and 24-MAR-1999, a first, second, third, and fourth dose of poliovirus vaccine on 19-MAY-1998, 16-JUL-1998, 24-MAR-1999, and 28-MAR-2002, and a first and second dose of MMR II (manufacturer unknown) on 24-MAR-1999 and 28-MAR-2002. Other therapy included a first, second, and third dose of hepatitis B virus vaccine (manufacturer unknown) on 24-MAR-1998, 19-MAY-1998, and 15-SEP-1998, and a 0.5 mL dose of Fluzone (Lot 3 U1172AA) on 12-DEC-2003. On 09-MAR-2006 the patient experienced breakthrough chickenpox. Subsequently, the patient recovered. No additional information is expected.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Folliculitis, Rash vesicular
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a 7-year-old female who on 29-NOV-1999 was vaccinated at another facility with a dose of Varivax. On 01-MAY-2006 the patient developed vesicles on her thigh, right axilla and abdomen. On 03-MAY-2006 the patient was seen in the physician's office. The reported noted that she had a total of 30 vesicles and at the time of the report she had not recovered. No product quality complaint was involved. Additional information was received from a R.N. on 25-AUG-2006 indicating that the patient recovered from the vesicles that were seen on 03-MAY-2006. The R.N. indicated that it was questionable if it was true varicella. It was also reported that on 02-JUN-2006 the child broke out with a similar rash that was diagnosed as folliculitis. The outcome was reported as recovered. Additional information is not expected.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a licensed visiting nurse concerning a 7 year old female who on 05-JUL-2000 was vaccinated with a dose of Varivax. On 02-MAR-2006, the patient was evaluated by a physician and had over 100 lesions. The patient was determined to have varicella. A product quality complaint was not involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a licensed practical nurse (L.P.N) concerning a 7-year-old female child, who on 25-FEB-2000 was vaccinated with a first dose of Varivax (lot# 631065/0445J). On 06-APR-2006 the patient was examined by a physician and diagnosed with chickenpox. No outcome was reported. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a licensed practical nurse (L.P.N.) concerning a 7-year-old white male who on 22-DEC-1999 was vaccinated subcutaneously in the right leg with a first dose of Varivax (lot# 631776/1351J). Subsequently, the patient developed what the physician diagnosed as chickenpox. No outcome was reported. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: VARCEL
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning an 8-year-old female with a peanut allergy, who on 30-NOV-1998 was vaccinated with a dose of Varivax (lot# not available). There was no illness at the time of vaccination. On 26-APR-2006 the patient developed a red, itchy rash with approximately 12 lesions. It was reported that the patient's rash was diagnosed on 01-MAY-2006 when the lesions were crusted over; though no diagnosis was reported. No diagnostic or laboratory were performed. It was noted that the patient recovered on 01-MAY-2006. No further information is available.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Body temperature
Clinical narrative: Information has been received from a health professional concerning a 7 year old white female, with no known drug allergies, who on 09-OCT-2002 was vaccinated with a first dose of Varivax (Lot# 643118/0503M). There was no illness at the time of vaccination and no adverse events following prior vaccination. On 22-APR-2006 the patient experienced 50 vesicles on her back and trunk. It was noted that there was no fever. Subsequently, the patient recovered. Medical attention was not sought. Additional information is not expected.
Age: 1.2
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a woman in a physician's office concerning an 8 year old male who on 23-FEB-1999 was vaccinated in the left arm with a first dose of Varivax (lot # 628149/1325H). On 02-MAY-2006, the patient developed less than 50 lesions and recovered on an unspecified date. Additional information is not expected.